Following the Adelphi Care acquisition last month, The Montreux Healthcare Fund posted a c.6% return across its share classes, exhibiting the arbitrage that is still present in the market and further underpinning the Fund’s investment strategy. This initial uplift is likely to be supplemented with further positive returns in the ensuing months as the business is driven forward, pushing up EBITDA and ultimately, improving the care standards of the acquired business yet further.

Oliver Harris, CEO, Montreux Capital Management stated: “The acquisition of Adelphi Care and the subsequent fund performance has met with much approval amongst our investor base. It is a solid demonstration of an investment philosophy with which our investors are very familiar and we hope to see further performance in the coming months as care standards and efficiencies are driven forward. The Regard Group remains one of the strongest businesses in the Specialist Care Sector and this acquisition can only serve to supplement its already strong position”.